Exploring common genetic contributors to neuroprotection from amyloid pathology

Author:

Seto Mabel123ORCID,Mahoney Emily R.124,Dumitrescu Logan124ORCID,Ramanan Vijay K.5ORCID,Engelman Corinne D.678,Deming Yuetiva678ORCID,Albert Marilyn9,Johnson Sterling C.78,Zetterberg Henrik10111213ORCID,Blennow Kaj1011,Vemuri Prashanthi14ORCID,Jefferson Angela L.14,Hohman Timothy J.1234,

Affiliation:

1. Vanderbilt Memory and Alzheimer’s Center, Vanderbilt University Medical Center, 1207 17th Ave S, Nashville, TN 37212, USA

2. Vanderbilt Genetics Institute, Vanderbilt University Medical Center, Nashville, TN 37212, USA

3. Department of Pharmacology, Vanderbilt University, Nashville, TN 37232, USA

4. Department of Neurology, Vanderbilt University Medical Center, Nashville, TN 37232, USA

5. Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA

6. Department of Population Health Sciences, University of Wisconsin, School of Medicine and Public Health, Madison, WI 53726, USA

7. Alzheimer’s Disease Research Center, University of Wisconsin School of Medicine and Public Health, Madison, WI 53792, USA

8. Geriatric Education and Clinical Center, Wm.S.Middleton VA Hospital, Madison, WI 53705, USA

9. Department of Neurology, the Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA

10. Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at University of Gothenburg, Mölndal 413 90, Sweden

11. Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal 413 45, Sweden

12. Department of Neurodegenerative Disease, UCL Institute of Neurology, London WC1N 3BG, UK

13. UK Dementia Research Institute at UCL, London WC1E 6BT, UK

14. Department of Radiology, Mayo Clinic, Rochester, MN 55905, USA

Abstract

Abstract Preclinical Alzheimer’s disease describes some individuals who harbour Alzheimer’s pathologies but are asymptomatic. For this study, we hypothesized that genetic variation may help protect some individuals from Alzheimer’s-related neurodegeneration. We therefore conducted a genome-wide association study using 5 891 064 common variants to assess whether genetic variation modifies the association between baseline beta-amyloid, as measured by both cerebrospinal fluid and positron emission tomography, and neurodegeneration defined using MRI measures of hippocampal volume. We combined and jointly analysed genotype, biomarker and neuroimaging data from non-Hispanic white individuals who were enrolled in four longitudinal ageing studies (n = 1065). Using regression models, we examined the interaction between common genetic variants (Minor Allele Frequency >0.01), including APOE-ɛ4 and APOE-ɛ2, and baseline cerebrospinal levels of amyloid (CSF Aβ42) on baseline hippocampal volume and the longitudinal rate of hippocampal atrophy. For targeted replication of top findings, we analysed an independent dataset (n = 808) where amyloid burden was assessed by Pittsburgh Compound B ([11C]-PiB) positron emission tomography. In this study, we found that APOE-ɛ4 modified the association between baseline CSF Aβ42 and hippocampal volume such that APOE-ɛ4 carriers showed more rapid atrophy, particularly in the presence of enhanced amyloidosis. We also identified a novel locus on chromosome 3 that interacted with baseline CSF Aβ42. Minor allele carriers of rs62263260, an expression quantitative trait locus for the SEMA5B gene (P = 1.46 × 10−8; 3:122675327) had more rapid neurodegeneration when amyloid burden was high and slower neurodegeneration when amyloid was low. The rs62263260 × amyloid interaction on longitudinal change in hippocampal volume was replicated in an independent dataset (P = 0.0112) where amyloid burden was assessed by positron emission tomography. In addition to supporting the established interaction between APOE and amyloid on neurodegeneration, our study identifies a novel locus that modifies the association between beta-amyloid and hippocampal atrophy. Annotation results may implicate SEMA5B, a gene involved in synaptic pruning and axonal guidance, as a high-quality candidate for functional confirmation and future mechanistic analysis.

Funder

Intramural Research Program

National Institute on Aging

National Institutes of Health

Vanderbilt University Advanced Computing Center for Research and Education

Vanderbilt Institute for Clinical and Translational Research

Swedish Research Council

European Research Council

Clinical Research

Alzheimer’s Drug Discovery Foundation

UK Dementia Research Institute at University College London

Alzheimer Drug Discovery Foundation

Swedish Alzheimer Foundation

County Councils

European Union Joint Program for Neurodegenerative Disorders

Department of Defense

National Institute of Biomedical Imaging and Bioengineering

University of Southern California

Publisher

Oxford University Press (OUP)

Subject

General Earth and Planetary Sciences,General Environmental Science

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3